Antwan Girgis earned a B.S. in chemistry from Tanta University in Egypt in 2006. He joined Dr. Blagg’s lab in 2011 and worked on the synthesis of Novious Sugar and the synthesis and evaluation of Novologues as C-Terminal Hsp90 inhibitors. He will graduate with a Pharm.D. degree from the University of Kansas Pharmacy School in May 2016. He contributed to multiple publications through Prof. Blagg’s lab, including “Novologues containing a benzamide side chain manifest anti-proliferative activity against two breast cancer cell lines.